These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6614939)

  • 41. Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT).
    Björkstrand B; Svensson H; Goldschmidt H; Ljungman P; Apperley J; Mandelli F; Marcus R; Boogaerts M; Alegre A; Remes K; Cornelissen JJ; Bladé J; Lenhoff S; Iriondo A; Carlson K; Volin L; Littlewood T; Goldstone AH; San Miguel J; Schattenberg A; Gahrton G
    Bone Marrow Transplant; 2001 Mar; 27(5):511-5. PubMed ID: 11313685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant alpha-interferon as salvage therapy in multiple myeloma. A pilot study.
    Jacobs P; Le Roux IM; Wood L; King HS
    S Afr Med J; 1989 Aug; 76(3):100-2. PubMed ID: 2762938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Interferon as a sensitizing agent toward chemotherapy in a case of multiple myeloma refractory to treatment].
    Seminara P; Codacci-Pisanelli G; Aronne T; Ercoli L; Avella A; Bonomo L
    Recenti Prog Med; 1988 Oct; 79(10):415-6. PubMed ID: 3247510
    [No Abstract]   [Full Text] [Related]  

  • 44. Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status.
    Kröger N; Zabelina T; Ayuk F; Atanackovic D; Schieder H; Renges H; Zander A
    Exp Hematol; 2006 Jun; 34(6):770-5. PubMed ID: 16728282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. All-trans retinoic acid in combination with alpha-interferon and dexamethasone for advanced multiple myeloma.
    Musto P; Sajeva MR; Sanpaolo G; D'Arena G; Scalzulli PR; Carotenuto M
    Haematologica; 1997; 82(3):354-6. PubMed ID: 9234591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical use of interferon alfa-2b (intron-A): the Manchester experience.
    Scarffe JH; Wagstaff J; Crowther D
    Ann Ist Super Sanita; 1987; 23(4):777-8. PubMed ID: 3452285
    [No Abstract]   [Full Text] [Related]  

  • 47. Dexamethasone, paclitaxel, etoposide, cyclophosphamide (d-TEC) and G-CSF for stem cell mobilisation in multiple myeloma.
    Bilgrami S; Bona RD; Edwards RL; Li Z; Naqvi B; Shaikh A; Furlong F; Fox J; Clive J; Tutschka PJ
    Bone Marrow Transplant; 2001 Jul; 28(2):137-43. PubMed ID: 11509931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma.
    Quesada JR; Hawkins M; Horning S; Alexanian R; Borden E; Merigan T; Adams F; Gutterman JU
    Am J Med; 1984 Sep; 77(3):427-32. PubMed ID: 6548079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical effects of human fibroblast interferon in advanced gynecological cancers].
    Kanazawa K; Honma S; Yuzawa H; Takeuchi S
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1276-83. PubMed ID: 6732254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group].
    Krejcí M; Hájek R; Scudla V; Bacovský J; Indrák K; Faber E; Koza V; Schützová M; Kuca B; Sumná E; Franková H; Lehanka F; Gumulec J; Stavarová Y; Rezek Z; Praskac P; Cahová S; Vránová M; Veprek K; Januska J; Kessler P; Pozdĕnová V; Walterová L; Stefánek I; Hausdorf P; Meluzínová I; Novosadová L; Lenícková S; Dusek L; Syobodník A; Králová E; Adam Z; Mayer J; Vorlícek J
    Vnitr Lek; 2001 Sep; 47 Suppl 1():40-7. PubMed ID: 11693062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Feasibility and pharmacokinetics of continuous subcutaneous infusion of low-dose interferon-gamma: a pilot study.
    Satake I; Tari K; Nakagomi K; Ozawa K
    Jpn J Clin Oncol; 1993 Dec; 23(6):356-62. PubMed ID: 8283789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
    Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant alpha-interferon improves complete remission rates following allogeneic transplantation for multiple myeloma.
    Byrne JL; Carter GI; Bienz N; Haynes AP; Russell NH
    Bone Marrow Transplant; 1998 Oct; 22(7):639-43. PubMed ID: 9818690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum beta-2-microglobulin in patients with multiple myeloma treated with alpha interferon.
    Murakami H; Ogawara H; Morita K; Saitoh T; Matsushima T; Tamura J; Sawamura M; Karasawa M; Miyawaki S; Schimano S; Satoh S; Tsuchiya J
    J Med; 1997; 28(5-6):311-8. PubMed ID: 9604789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of interferon alpha-2b in advanced multiple myeloma.
    Rödjer S; Vikrot O; Wahlin A; Westin J
    J Intern Med; 1990 Jan; 227(1):45-8. PubMed ID: 2299297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Natural type interferon-alpha (Namalwa) therapy for multiple myeloma complicated by hemolytic anemia].
    Sone Y; Kawano F; Nishimura Y; Kurisaki H; Tsukamoto A; Kiyokawa T; Sanada I; Shido T
    Rinsho Ketsueki; 1993 May; 34(5):670-2. PubMed ID: 8315840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alpha interferon raises serum beta-2-microglobulin in patients with multiple myeloma.
    Tienhaara A; Remes K; Pelliniemi TT
    Br J Haematol; 1991 Mar; 77(3):335-8. PubMed ID: 2012758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of non-hodgkin's lymphoma of low-grade malignancy with human fibroblast interferon.
    Siegert W; Theml H; Fink U; Emmerich B; Kaudewitz P; Huhn D; Böning L; Abb J; Joester KE; Bartl R; Riethmüller G; Wilmanns W
    Anticancer Res; 1982; 2(4):193-8. PubMed ID: 7149647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial.
    Krown SE; Burk MW; Kirkwood JM; Kerr D; Morton DL; Oettgen HF
    Cancer Treat Rep; 1984 May; 68(5):723-6. PubMed ID: 6722830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.